Double Core-Shell Micelle, Liposomes, Albumin, LNP
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
36
NCT04640480
Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 21, 2024
Completion: Jun 30, 2025
Loading map...